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Inferior vena cava (IVC) leiomyosarcoma is a rare malignant neoplasm more commonly seen in women in the fifth
to sixth decade of life. Complete resection of the tumor with negative margins is the only therapeutical option
that has demonstrated a survival benefit. This report presents a case of a 67-year-old woman affected by a lower
segment IVC leiomyosarcoma incidentally detected during a chronic abdominal pain study. The patient was
treated with tumorectomy, resection and ligation of the infrarenal IVC without signs or recurrence on a
12-month follow-up.
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Soft tissue retroperitoneal leiomyosarcomas are rare ma-
lignant tumors that account for 0.5% of all sarcomas in
adults and carry a poor outcome [1-3]. The vascular sys-
tem is the most commonly affected arising from the
smooth muscle cells of the inferior vena cava (IVC) in
half of the cases [1,4,5]. It is more common in women in
the fifth to sixth decade of life [1]. Diagnosis may be de-
layed with presenting features ranging from asymptom-
atic, due to their deep origin, to non-specific symptoms,
due to compression, that may include palpable abdom-
inal mass, abdominal pain, lower limb edema, throm-
bosis, and venous stasis [1,6]. Most information about
treatment comes from case reports or small series, and
complete resection of the tumor with negative margins
is the only therapeutical option that has demonstrated a
survival benefit [3,7-9].
We present a case of a lower segment IVC leiomyosar-
coma incidentally detected during a chronic abdominal
pain study. Authors and the patient as well consent to
publish the information below about this case report.Case presentation
The patient is a 67-year-old woman with relevant med-
ical history of colon cancer treated with hemicolectomy,
radiation, and chemotherapy 14 years ago without* Correspondence: karla_moncayo@hotmail.com
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in any medium, provided the original work is precurrence during the follow-up. The patient had several
visits to the emergency room for immediate postprandial
abdominal pain (especially epigastric and on upper quad-
rants) as well as nausea, vomiting, and significant weight
loss during the last 18 months. Ultrasound demonstrated
thrombosis of the inferior vena cava at epigastric level with
an 80 × 30 mm thrombus. Computed tomography (CT
scan) revealed a retroperitoneal heterogeneous soft tissue
density mass that involved the infrarenal IVC without af-
fecting the iliac veins of 8 × 4.6 cm in size and no evidence
of metastatic disease (Figures 1 and 2). Celiac and mesen-
teric arteries were patent without stenosis. A biopsy of the
tumor wall was conducted through a median laparotomy,
because of technical difficulties by laparoscopic approach
due to previous abdominal surgery and pericava localization
of the tumor. As there was no definitive intraoperative diag-
nosis and the patient was not informed about the therapeu-
tical procedure, tumor extirpation was postponed until
pathology results were available and so the patient can be
fully informed, as well. Pathologic study demonstrated a
fusocellular stromal tumor, showing fascicles which inter-
sect at 90°, histochemically and immunohistochemically
concordant with IVC leiomyosarcoma (LMS).
Surgical approach by transverse abdominal incision is
done, and the retroperitoneal mass arising from segment
I IVC was exposed through a Kocher maneuver and
right colon mobilization from the renal to the iliac veins.
Inflammatory tissue and fibrosis were found and dis-
sected carefully to preserve the surrounding structures,is an open access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 CT scan image. Coronal view showing retroperitoneal
heterogeneous soft tissue density mass that compresses and







Figure 3 Intraoperative image showing inferior vena cava
leiomyosarcoma during tumorectomy (black arrow). Ao, aorta;
RCIA, right common iliac artery; LCIA, left common iliac artery; L4,
fourth lumbar vertebra; L5, fifth lumbar vertebra; RU, right ureter.
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resection and ligation of the infrarenal IVC, was made
leaving the iliac veins patent (Figure 3).
The specimen was composed of nine pieces, the prin-
cipal of 7.5 × 3.5 × 2.5 cm in diameter, diagnosed as
moderately differentiated IVC LMS, with frequent areasFigure 2 CT scan image. Axial view showing retroperitoneal heterogeneo
infrarenal IVC (white arrow).of hyalinization, foci of nuclear hyperchromatism and pleo-
morphism, and images of intraluminal growth (Figure 4A).
Immunohistochemically, tumor cells were positive with
smooth muscle markers (Figure 4B).
One week after the intervention, the patient developed
an acute episode of hypotension, anemization, and se-
vere abdominal wall hematoma due to spontaneous
bleeding from epigastric collateral vessels probably sec-
ondary to anticoagulation therapy, which required rein-
tervention for drainage and hemostasis. Postoperatively,
mild lower limb edema was observed without signs ofus soft tissue density mass that compresses and thrombosis the
A B
Figure 4 Inferior vena cava leiomyosarcoma histological features. (A) Microphotograph of the tumor with hematoxylin and eosin stain
showing moderately differentiated IVC leiomyosarcoma, with frequent areas of hyalinization, foci of nuclear hyperchromatism and pleomorphism,
and images of intraluminal growth. (B) Microphotograph of immunohistochemical actin stain, showing positive tumor cells with smooth
muscle markers.
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Afterwards, the clinical outcome was satisfactory, and
upon discharge, the patient was anticoagulated first with
low molecular weight heparin and then changed to ace-
nocumarol with a target INR between 2 and 3.
At 12-month follow-up, the patient has no abdominal
pain, and the CT shows that there are no radiologic
signs of recurrence. Meanwhile, she is on a careful
follow-up program by the oncology department, and no
adjuvant therapy has been performed.
Discussion
Malignant soft tissue tumors (STT) account for <1% of
malignant tumors in adults. LMS make up less than 5%
of these STT, and specifically vascular LMS accounts
0.7% of all STT [10]. Two percent of LMS originates
from the vascular system being IVC, the most com-
monly involved [1]. Retroperitoneal sarcomas are un-
common, constituting 10% to 15% of all soft tissue
sarcomas (STS) with an average annual incidence of
approximately 2.7 cases per million population [11]. The
mean age of presentation is 53 years with a female:male
ratio of 3:1 [12].
IVC LMS usually has a delayed clinical presentation
due to slow growth and retroperitoneal location with
intraluminal and/or extraluminal extension and spread-
ing by local expansion along adjacent low-resistance
structures [1,6]. Metastases are initially spread hemato-
genously and subsequently through lymph nodes and
can involve the liver, lung, and/or bones [13]. Anatomic-
ally, IVC is divided in three segments, and according to
the level affected by the tumor, the symptoms may vary.
Segment I involvement (infrarenal IVC) usually pre-
sents with pedal edema and abdominal distention.
Segment II (middle segment of IVC, from renal
to hepatic veins) with nephrotic and/or Budd-Chiarisyndrome. Segment III (above hepatic veins) with pul-
monary embolism [1,6,9].
Retroperitoneal LMS is more often diagnosed on CT
or MRI. CT scan is the imaging modality of choice for
evaluation of the tumor [14]. Coronal and sagittal slices
of contrast-enhanced CT can reliably detect the origin
and extension of it or if metastases are present, helping
the preoperative surgical planning and determining the
prognosis. Hypodense retroperitoneal mass involving the
IVC with heterogeneous post contrast enhancement is
the most common imaging presentation. Hence, an IVC
LMS should be suspected whenever it is seen as hetero-
geneously enhancing as a retroperitoneal mass along the
IVC [6,14]. Radiographic findings that indicate unresect-
ability are peritoneal implants, distant metastases, in-
volvement of the root of the mesentery, and spinal cord
involvement [15]. In our case, we decided to confirm the
diagnosis with biopsy of the tumor in order to be sure
that it was not a recurrence of her previous colon
cancer.
The only curative treatment that has been proved for
IVC LMS is complete resection of the tumor with free
margins. Adjuvant radiation and chemotherapy remains
controversial and unclear [2,4,7,12,16,17]. Surgical op-
tions include partial resection and primary cavoplasty,
complete resection and graft placement, and ligation of
IVC. The latter can be performed uneventfully if a good
collateral network has been developed before IVC occlu-
sion or if it has not affected segment III IVC as it hap-
pened in our patient [3,7-9].
It has been described by Ferrario et al. on a study of
130 patients with retroperitoneal STS that local recur-
rence rate after local excision is 63% and after wide exci-
sion 39% (P < .02). The estimated 5- to 10-year survival
with local recurrence was 54% and 39%, respectively,
and without local recurrence 66% and 58%, respectively
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first surgery was 60% and 10-year survival 48%. Prognos-
tic factors for survival were the grade (P < .001) followed
by the procedure, wide versus local excision (P < .01),
whereas tumor size was not significant [18]. According
to Italiano et al. on a study of 1,472 patients with sar-
coma, vascular origin is an independent adverse prog-
nostic factor for metastasis-free survival and overall
survival [19]. Meanwhile, Laskin et al. on a study of 40
patients with IVC LMS demonstrated that level III IVC
and right atrial involvement by sarcoma, intraluminal
growth, compromised liver, and residual postsurgical
macroscopic disease negatively impact on clinical course
of the disease [12].
Conclusions
An enhanced retroperitoneal heterogeneous mass along
the IVC should be a warning, and consideration of diag-
nosis of IVC LMS and an aggressive resection of it
should be made as it is the only treatment that has
proven survival benefits.
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